Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo PCI, and can lower the risk of death or major bleeding by 31 percent.
Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo PCI, and can lower the risk of death or major bleeding by 31 percent.
